⚖️ Cannabis M&A Under The Microscope: Connecticut’s $416k Antitrust Fine

Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.

Today’s edition is brought to you by Wispr Flow and Beehiiv. We break down the forensic shift in Connecticut, where regulators are using antitrust settlements to police the messy interim period of acquisitions. From Governor Hochul’s push for a tax overhaul in New York to the administrative shutdown looming in Texas, regulators are increasingly using procedural tools to enforce market stability. We also dive into the new Medicare lane for clinical counseling and the rising petition wars threatening mature markets across New England.

To sponsor Policy, Decoded and reach the executives, investors, and policymakers who read this briefing, reply to this email and we will send details.

⚖️ M&A Under The Microscope
🍎 New York Tax Overhaul
🩺 The Medicare Lane

Check your interim covenants before the state checks them for you.

📌 What Happened: Connecticut Attorney General William Tong finalized a $416,000 settlement on Monday with three dispensaries operating as Crisp Cannabis and their prospective buyer Mohave CT, LLC for illegal gun jumping. The investigation revealed that Mohave assumed de facto operational control over the stores more than 100 days before the parties filed the mandatory pre-merger notification required under state law. While the deal was ostensibly in the planning phase, the acquiring entity was already dictating pricing strategies and making core staffing decisions. The settlement includes an immediate $104,000 penalty and a three-year monitoring period backed by an additional $312,000 in suspended fines. Investigators identified a general contractor, Tigersun Services, as the primary vehicle for this premature integration. This contractor exercised managerial authority that went far beyond site construction to include hiring and compliance oversight.

💡 Why It Matters: This enforcement action is the first of its kind in the nation and exposes a critical vulnerability in the standard acquisition playbook for cannabis. Connecticut law contains a unique grand bargain where the state holds powerful antitrust review tools while making the underlying filings permanently exempt from public disclosure. By acting before this review window opened, Mohave and Crisp effectively bypassed the state's ability to assess whether the merger would create a localized monopoly. The Attorney General’s move confirms the state will look past the formal closing date to examine the undocumented transition period where buyers often try to protect their investment by taking the wheel early. The use of routine records like internal pricing emails and vendor contracts to reconstruct this timeline suggests that regulators are now sophisticated enough to spot the difference between integration planning and integration execution.

🍎 New York Budget Proposal Targets Potency Tax Repeal

Governor Kathy Hochul is proposing a major overhaul of New York’s cannabis tax structure by calling for the total repeal of the state’s complex potency tax. The governor wants to replace the current THC-based calculation with a flat 9% wholesale excise tax to simplify operations for distributors and reduce retail price pressure. This shift is paired with a request for expanded enforcement authority that would allow local governments to padlock unlicensed storefronts without waiting for state-level intervention. Legal operators have long argued that the potency tax made lab testing a liability and inflated the cost of high-potency products. If the legislature approves the package, it will represent the most significant effort yet to salvage the state’s struggling retail rollout through a combination of tax relief and local police powers. (Cannabis Wire)

⚖️ Cresco Pushes To Toss Labeling Class Action On No Harm Theory

Cresco Labs moved to dismiss a federal class action lawsuit in Illinois by arguing that technical labeling disputes belong under the jurisdiction of state regulators. The company asserts that the plaintiffs failed to plead any concrete injury or financial loss resulting from allegedly mislabeled vape oils. This legal strategy attempts to prevent plaintiffs' attorneys from using regulatory classification errors as the basis for broad consumer fraud claims. Judges are now being asked to decide if a lack of physical or financial harm should bar such suits from moving forward at the pleading stage. A ruling in Cresco’s favor would provide a significant shield for operators against no-harm litigation across multiple jurisdictions. (Tobacco Reporter)

🧑‍🌾 New Jersey Moves To Close Cannabis Labor Protections Gap

New Jersey lawmakers sent a cannabis worker protection bill to Governor Phil Murphy that creates specific penalties for retaliation against employees involved in labor organizing. The legislation places enforcement authority under the State Board of Mediation and allows for remedies including back wages and other monetary relief. A notable provision in the text establishes a penalty structure with exposure reaching $5,000 per day for each day an operator remains in noncompliance. This legislation elevates labor relations to a primary regulatory compliance risk for multi-site operators. Management will be forced to implement rigorous supervisor training and documentation protocols to mitigate the risk of compounding daily fines. (Safety+Health)

🚫 New Jersey Signs Phased Intoxicating Hemp Ban With A Clear Channel Shift

Governor Phil Murphy signed a legislative package on Monday that formally moves intoxicating hemp products into the state’s licensed cannabis regulatory system. The new law establishes a strict 0.3% total THC limit and sets a firm April 13th deadline for retailers to liquidate any inventory that exceeds the new standards. This move replaces a previously litigated 2024 statute and resolves ongoing confusion regarding the legality of hemp-derived cannabinoids in traditional retail settings. Liquor stores are permitted to sell potency-limited hemp beverages through a temporary window that closes in November as federal rules tighten. The operational result is a centralized market where all intoxicating products are governed by the Cannabis Regulatory Commission. Businesses failing to clear non-compliant stock by the spring deadline face escalating civil penalties and potential nuisance designations. (Heady NJ)

🤠 Texas Hemp Rules Put The Market On A Short Fuse

Texas health officials have introduced proposed rules for consumable hemp that would adopt a total THC accounting standard for all retail products. This shift would require manufacturers to include THCA in the legal limit calculation and effectively reclassify a significant portion of current inventory as a controlled substance. During recent public hearings, industry participants highlighted that these new definitions favor large scale operators with the capital to overhaul production lines while pricing out smaller retailers. Market participants are already responding by pausing capital projects and pulling specific SKUs in anticipation of a much smaller legal shelf. The resulting regulatory friction will likely trigger immediate litigation over state administrative authority and federal preemption. (Cannabis Wire)

🗳️ Maine Repeal Petition Turns Into A First Amendment Fight

A campaign to repeal Maine’s legal cannabis sales is facing scrutiny for allegedly misrepresenting its goals as a simple safety and testing upgrade to voters. Secretary of State Shenna Bellows has indicated that her office has limited authority to intervene, as political speech protections generally protect circulator claims made at the clipboard. This hands-off approach places the burden of correction on the industry, which must now fund real-time rebuttal campaigns to inform the public. The lack of a state-level truth in petitioning standard allows the repeal effort to gain momentum through procedural confusion. Operators and landlords are already pricing in the risk that a mature market could be dismantled through these ballot mechanics. (Maine Morning Star)

📜 Massachusetts Repeal Petition Faces A Fast Evidence Test

The Massachusetts State Ballot Law Commission began hearings this week to determine if a petition to repeal adult-use retail should be disqualified over alleged signature fraud. Challengers must invalidate roughly 3,500 signatures to knock the measure off the ballot, focusing on claims that paid circulators told voters the initiative would protect the industry. Proponent attorneys argue that verbal misrepresentations by contractors rarely meet the legal threshold for disqualifying signatures when the underlying petition text is accurate. This administrative fight tests whether the state will police the high-pressure environment of professional signature gathering or defer to the signed record. A ruling in favor of the proponents would force the industry into a costly defensive campaign that threatens the permanence of current retail licenses. (State House News Service)

🌴 Hawaii Legalization Framework Faces Editorial Backlash

The Honolulu Star-Advertiser editorial board is signaling a sharp rejection of the state’s current legalization trajectory as the 2026 legislative session opens. Critics are targeting the Attorney General-drafted model for its heavy focus on law enforcement expansion, including the creation of a drug nuisance abatement unit and dozens of new police positions. The editorial argues that the 300-page framework leans too heavily on re-criminalizing innocuous conduct, such as visible home-grown plants or unsealed packages in vehicles, rather than prioritizing social equity or market entry. This regulatory posture has fractured the pro-reform coalition, with civil rights advocates and industry hopefuls both wary of the bill's punitive tilt. The consequence is a stalled political momentum that threatens to leave Hawaii as one of the few remaining states without a functional adult-use retail channel. (Honolulu Star-Advertiser)

🌎 2026 Legalization Map Comes Into View

The 2026 legalization landscape is shifting from geographic expansion to the defense of existing state programs against well-funded repeal initiatives. Florida’s adult-use campaign is currently navigating a significant setback after a state judge invalidated 200,000 signatures, forcing the effort into a high-stakes appeal to maintain its February qualification deadline. In Virginia, the conversation has moved from if to how, with newly introduced legislation proposing a statewide retail launch in November that would notably prohibit local opt-outs. Federal rescheduling and recent executive orders are providing new political cover for expansion in conservative states like New Hampshire, while simultaneously emboldening repeal advocates in mature markets. This dual-track environment requires institutional capital to weigh the potential for new market entries against the risk of total rollbacks in established jurisdictions. The year will be defined by whether the industry can prove its legitimacy in the face of organized opposition that targets the very mechanics of the ballot process. (Marijuana Moment)

🍑 Georgia Lawmakers Revisit Medical Potency Limits

Georgia lawmakers opened the 2026 legislative session facing a renewed push to raise the state’s restrictive medical potency ceiling. Advocates are prioritizing a legislative jump from the current 5% THC limit to 50% while attempting to authorize vaping as a delivery method. These proposals follow a summer of testimony from a blue ribbon committee that highlighted the gap between current patient access and clinical needs. Political resistance in the House remains the primary obstacle after a similar expansion failed to gain traction in the chamber last year. The outcome of these debates will decide if Georgia’s medical market remains a narrow niche or transitions into a commercially viable statewide program. (WGAU Radio)

🩺 CMS LEAD Model Opens A Medicare Lane For Hemp Counseling

A new CMS accountable care model for dementia management is prompting healthcare attorneys to review how clinicians can formally discuss state-legal cannabinoids with patients. While the model does not change the federal status of cannabis or provide direct Medicare reimbursement, it creates a structured environment for clinical documentation and patient risk assessment. This development marks a transition from informal patient recommendations to formal care management integrated within the standard medical system. Healthcare providers are expected to demand pharmaceutical-grade traceability and consistent dosing from any products they acknowledge in these patient records. Brands that cannot meet these rigorous clinical standards will be locked out of the emerging professional referral networks. (Foley Hoag)

🏔️ Montana Adult Use Clears $1 Billion As Medical Share Collapses

Montana has officially recorded more than $1 billion in total adult-use sales since the market launched four years ago. This milestone highlights a significant shift in consumer behavior as the state medical program continues to lose market share to the retail channel. Many patients are choosing to exit the registry to avoid annual card fees and privacy concerns while finding sufficient product variety in adult-use stores. The sustained tax yield has effectively converted previous legalization opponents into budget pragmatists who now view the program as an essential revenue stream. This shift is forcing a legislative debate over the long-term viability of maintaining a separate medical infrastructure for a shrinking patient base. (Montana Free Press)

🗺️ Leafly Top 100 List Shows Where Retail Reputation Concentrates

Leafly released its annual Top 100 US Dispensaries rankings for 2025, identifying JARS Cannabis in Phoenix as the top-rated retail location in the country. The selection process utilized a weighted scoring model that required a minimum 4.7 customer rating and at least 50 reviews while capping winners at 20 per state to ensure geographic diversity. Results show high performance clusters in Arizona and Maryland, where regulatory maturity has incentivized operators to run retail locations as disciplined systems rather than simple storefronts. The list also features a significant number of pharmacist-led and minority-owned independent shops that are currently outperforming larger multi-state brands in customer retention metrics. This data provides a measurable proxy for local management quality and consumer trust in increasingly saturated markets. Maintaining these high service standards is becoming a primary defense against the pricing pressure seen in more established jurisdictions. (Leafly)

📊 Canada Survey Shows Who Still Buys Outside The Legal Channel

A new survey from Research Co. reveals that 70% of Canadian cannabis consumers have migrated to the legal market, yet only 48% report buying exclusively through licensed channels. British Columbia and Quebec continue to underperform in legal conversion rates, indicating that legacy market infrastructure in these provinces remains a formidable competitor to the regulated system. Older consumers exhibit a polarized behavior pattern, reporting either total compliance with legal retail or a complete reliance on illicit sources. Data across ethnic and political lines shows that East and South Asian respondents, along with Liberal and Conservative voters, are the groups most likely to purchase exclusively from licensed stores. This participation gap underscores the reality that legal market share is directly tied to retail density and price parity. Provincial authorities will likely prioritize tax and licensing reforms in lagging regions to protect the long-term viability of the legal industry. (StratCann)

🧪 Standard THC Units Get A Serious Public Health Test

Public health researchers are advocating for a five milligram standard THC unit to allow for direct potency comparisons across different product categories. This framework functions similarly to the standard drink measurement for alcohol by simplifying safety education and dosing guidance for the general public. Policymakers are showing interest in the model as a means to standardize labeling requirements and improve consumer risk assessments. Implementing this standard would force manufacturers to restructure their packaging math and multi-serve formats to align with a universal metric. The operational transition will require significant capital and time to update compliance software and labeling equipment. This standardization would eventually allow states to tie tax rates and potency caps to a specific unit count rather than total weight or volume. (Healthline)

🎥 Cannabis Imagery Shows Up In A Big Slice Of Top Rap Videos

Researchers at the German Institute for Therapy and Health Research analyzed the 2024 YouTube Top 100 and found that 37% of US hip-hop videos feature cannabis imagery. The study, funded by the German Ministry of Justice and Health, estimated that these depictions resulted in 49 billion cannabis impressions among global viewers last year. Public health advocates are pointing to this saturation as evidence that current digital advertising restrictions are failing to shield younger audiences from cultural normalization. The data highlights a significant gap between state-level marketing bans and the unregulated environment of global streaming platforms where legacy artists drive mainstream visibility. This finding is expected to fuel new legislative pressure for mandatory age-gating and safety warnings on music content that reaches adolescents. (Marijuana Moment)